EP Briefing 2002-05-13: No funding for reproductive human cloning, insist MEPs (retabling amendments)

Published on
May 9, 2002
Last updated
May 22, 2015

Brussels, 08 May 2002

In reaching its common position, the EU's Sixth Framework Programme for Research and Development, a five-year scheme with planned funding of €17.5bn, Council took on board numerous amendments approved by Parliament at first reading but was not able to come to an agreement on the wording of the legislation relating to cloning. The committee is therefore retabling the amendment from first reading which bans EU finance for research activity into human cloning for reproductive purposes, the creation of embryos for research purposes and research activity which would lead to the modification of the genetic heritage of human beings.

Amendments retabled from first reading support:

- health research to be extended beyond  the field of genomics;

the integration of sustainable development and the reduction of external environmental

      costs;- the promotion of basic research and space research;- the inclusion of research into health risks and health improvements;- increased participation of SMEs in all areas of the framework programme;- research into the preservation of the cultural heritage.

ADVERTISEMENT


Gérard CAUDRON (PES, F)
Report on the Council common position for adopting a European Parliament and Council decision on the Sixth Framework Programme of the European Community for research, technological development and demonstration activities, contributing to the creation of the European Research Area and to innovation (2002-2006)
(15483/3/2001 - C5-0036/2002 - 2001/0053(COD))
Doc.: A5-0153/2002 [may not be available yet]


Procedure: Codecision procedure (2nd reading)
Debate: 14.05.200

ADVERTISEMENT

European Parliament Briefing 2002-05-13

http://www.europarl.eu.int/home/default _en.htm

Register to continue

Why register?

  • Registration is free and only takes a moment
  • Once registered, you can read 3 articles a month
  • Sign up for our newsletter
Please
or
to read this article.

Sponsored

Featured jobs

See all jobs
ADVERTISEMENT